Industry News
Nearly 6% of cancers attributable to diabetes, high BMI
UK researchers have revealed that diabetes and high body-mass index were the cause of 5.6% of new cancer cases worldwide in 2012 — equivalent to 792,600 cases. [ + ]
Sequencing technology picks up the "spelling mistakes" in DNA
Researchers from South Australia are leading what they believe to be a genomic revolution — and they couldn't have done it without the help of nine-year-old Angus Bond. [ + ]
More than half of post-surgery antibiotic prescriptions are inappropriate
More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance. [ + ]
Heart attack or chest pain? Take this diagnostic test and find out
Upstream Medical Technologies has developed a biomarker-based diagnostic test to rule out the risk of imminent heart attack for the significant number of people presenting at hospital with chest pain. [ + ]
Protein analysis provides new insights into Down syndrome
European researchers have analysed the proteins of individuals with trisomy 21 — more commonly known as Down syndrome — for the first time. [ + ]
Bio-Gene Technology collaborates with CSIRO on insecticide development
Bio-Gene Technology, a manufacturer of insecticides, has entered into an extended research agreement with CSIRO to develop improved manufacturing systems for its lead product, Flavocide. [ + ]
LeafCann and WardMM partner for BPSD clinical trial
LeafCann Research and Advisory has signed a clinical trial agreement with WardMM to sponsor and provide medicinal cannabis extracts for the latter's research and development program for the treatment of behavioural and psychological symptoms of dementia (BPSD). [ + ]
Marine scientist Emma Johnston elected president of STA
Marine scientist and broadcaster Professor Emma Johnston has been elected president of Science & Technology Australia (STA). [ + ]
Strong anticancer activity identified in newly patented AAD compounds
PharmAust has been granted a new patent in the US covering its portfolio of anticancer drugs, recently proven to be more effective at killing cancer cells than their parent compound. [ + ]
Australian innovation celebrated in 2017 CSIRO Awards
The 2017 CSIRO Awards showcased the achievements of the national science agency's people and partners and the difference their research makes to industry, society and the planet. [ + ]
Griffith Uni celebrates new biobanking resource, MoU with Gold Coast Health
Griffith University is discussing a number of its recent initiatives as part the Gold Coast Health Research Week Conference. [ + ]
MEP Instruments rebrands as Metrohm Australia, Metrohm New Zealand
MEP Instruments will change its name to Metrohm Australia and Metrohm New Zealand, effective 1 January 2018. [ + ]
New TGA rules assist access to medical cannabis
The TGA has announced changes to its Special Access Scheme that will make it easier for medical practitioners to prescribe cannabis-based medicines for patients in need, under certain conditions. [ + ]
ANSTO awards Australia's standout nuclear scientists
The ANSTO Awards in Nuclear Science and Technology 2017 have been announced, celebrating a number of researchers for their work advancing nuclear science in Australia. [ + ]
New tool to better share clinico-genomic data
Spanish researchers have developed a new tool that enables clinico-genomic data to be easily shared among different institutions. [ + ]
